BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song J, Li Y, Bowlus CL, Yang G, Leung PSC, Gershwin ME. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review. Clin Rev Allergy Immunol. 2020;58:134-149. [PMID: 31463807 DOI: 10.1007/s12016-019-08764-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Picado C, de Landazuri IO, Vlagea A, Bobolea I, Arismendi E, Amaro R, Sellarés J, Bartra J, Sanmarti R, Hernandez-Rodriguez J, Mascaró JM, Colmenero J, Vaquero EC, Pascal M. Spectrum of Disease Manifestations in Patients with Selective Immunoglobulin E Deficiency. J Clin Med 2021;10:4160. [PMID: 34575269 DOI: 10.3390/jcm10184160] [Reference Citation Analysis]
2 Dondossola D, Ghidini M, Grossi F, Rossi G, Foschi D. Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma. World J Gastroenterol 2020; 26(25): 3542-3561 [PMID: 32742125 DOI: 10.3748/wjg.v26.i25.3542] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
3 Park J, Kim J, Kim S, Jung JH, Jang M, Park S, Lee M, Kim H, Suk KT, Kim DJ. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Biomedicines 2022;10:1288. [DOI: 10.3390/biomedicines10061288] [Reference Citation Analysis]
4 Saffioti F, Mavroeidis VK. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. World J Gastrointest Oncol 2021; 13(10): 1336-1366 [PMID: 34721770 DOI: 10.4251/wjgo.v13.i10.1336] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fuchs CD, Trauner M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat Rev Gastroenterol Hepatol. [DOI: 10.1038/s41575-021-00566-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Rabiee A, Silveira MG. Primary sclerosing cholangitis. Transl Gastroenterol Hepatol 2021;6:29. [PMID: 33824933 DOI: 10.21037/tgh-20-266] [Reference Citation Analysis]
7 Sawanyawisuth K, Sashida G, Sheng G. Epithelial-Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma. Cancers (Basel) 2021;13:791. [PMID: 33672838 DOI: 10.3390/cancers13040791] [Reference Citation Analysis]
8 Benson M, Pfau P. Probe-based confocal laser endoscopy and primary sclerosing cholangitis: Is seeing actually believing? Gastrointest Endosc 2021;94:577-9. [PMID: 34412828 DOI: 10.1016/j.gie.2021.05.015] [Reference Citation Analysis]
9 Gleeson D, Walmsley M, Trivedi PJ, Joshi D, Rea B. Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Can we be more proactive? Frontline Gastroenterol. [DOI: 10.1136/flgastro-2022-102172] [Reference Citation Analysis]
10 Li CM, Chen Z. Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation. Front Cell Dev Biol 2021;9:664305. [PMID: 34235145 DOI: 10.3389/fcell.2021.664305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Fung BM, Tabibian JH. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices. Expert Rev Gastroenterol Hepatol 2021;15:487-96. [PMID: 33682586 DOI: 10.1080/17474124.2021.1900732] [Reference Citation Analysis]
12 Azzam N, AlRuthia Y, Alharbi O, Aljebreen A, Almadi M, Loftus EV Jr. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease. Hepatol Int 2020;14:1114-24. [PMID: 33369708 DOI: 10.1007/s12072-020-10110-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Losurdo G, Gravina AG, Maroni L, Gabrieletto EM, Ianiro G, Ferrarese A; Young Investigator group of SIGE, the Italian Society of Gastroenterology. Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspective. Dig Liver Dis 2021:S1590-8658(21)00455-2. [PMID: 34509394 DOI: 10.1016/j.dld.2021.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ninfole E, Pinto C, Benedetti A, Marzioni M, Maroni L. Role of autophagy in cholangiocarcinoma: Pathophysiology and implications for therapy. World J Clin Cases 2021; 9(22): 6234-6243 [PMID: 34434990 DOI: 10.12998/wjcc.v9.i22.6234] [Reference Citation Analysis]
15 Manzia TM, Parente A, Lenci I, Sensi B, Milana M, Gazia C, Signorello A, Angelico R, Grassi G, Tisone G, Baiocchi L. Moving forward in the treatment of cholangiocarcinoma. World J Gastrointest Oncol 2021; 13(12): 1939-1955 [DOI: 10.4251/wjgo.v13.i12.1939] [Reference Citation Analysis]
16 Özdirik B, Müller T, Wree A, Tacke F, Sigal M. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. Int J Mol Sci 2021;22:6975. [PMID: 34203536 DOI: 10.3390/ijms22136975] [Reference Citation Analysis]
17 Dumonceau JM, Delhaye M, Charette N, Farina A. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1.Therap Adv Gastroenterol. 2020;13:1756284820927292. [PMID: 32595761 DOI: 10.1177/1756284820927292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
18 Dai M, Zhao X, Yu A, Zhao L, Kang Q, Yan S, Zhang X, Liu J. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients with Bile Duct Cancer: A Meta-Analysis. Nutr Cancer 2022;:1-13. [PMID: 35920450 DOI: 10.1080/01635581.2022.2104876] [Reference Citation Analysis]
19 Branchi V, Weismüller TJ, Zhou T, Henn J, Semaan A, Glowka TR, Gonzalez-Carmona M, Strassburg C, Kalff JC, Manekeller S, Matthaei H. [Surgical treatment of primary sclerosing cholangitis : Experiences from 30 years in a single center cohort with 173 consecutive patients]. Chirurg 2021;92:148-57. [PMID: 32488382 DOI: 10.1007/s00104-020-01197-5] [Reference Citation Analysis]
20 Zia HA, Siddiqui UD. Biliary Tract Malignancies Related to Gallbladder Polyps, Primary Sclerosing Cholangitis, and Choledochal Cysts. Clin Liver Dis (Hoboken) 2021;18:85-9. [PMID: 34584674 DOI: 10.1002/cld.1101] [Reference Citation Analysis]
21 Fujisawa T, Ushio M, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Okawa Y, Ochiai K, Tomishima K, Ishii S, Saito H, Isayama H. Role of Peroral Cholangioscopy in the Diagnosis of Primary Sclerosing Cholangitis. Diagnostics (Basel) 2020;10:E268. [PMID: 32365686 DOI: 10.3390/diagnostics10050268] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]